Abbonarsi

Valuing innovative endoscopic techniques: prophylactic clip closure after endoscopic resection of large colon polyps - 19/05/20

Doi : 10.1016/j.gie.2020.01.018 
Eric D. Shah, MD, MBA 1, Heiko Pohl, MD 1, 2, Douglas K. Rex, MD 3, Michael B. Wallace, MD, MPH 4, Seth D. Crockett, MD, MPH 5, Shannon J. Morales, MD 1, Linda A. Feagins, MD 6, 7, Ryan Law, DO 8,
1 Section of Gastroenterology and Hepatology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire 
2 Division of Gastroenterology, Department of Veterans Affairs, White River Junction, Vermont 
3 Division of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, Indiana 
4 Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, Florida 
5 Division of Gastroenterology and Hepatology, University of North Carolina School of Medicine, Chapel Hill, North Carolina 
6 Division of Gastroenterology, The University of Texas at Austin Dell Medical School, Austin, Texas 
7 VA North Texas Healthcare System, Dallas, Texas 
8 Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, Michigan, USA 

Reprint requests: Ryan Law, DO, Michigan Medicine Division of Gastroenterology and Hepatology, 1500 E Medical Center Drive, 3912 Taubman Center SPC 5362, Ann Arbor, MI 48109.Michigan Medicine Division of Gastroenterology and Hepatology1500 E Medical Center Drive3912 Taubman Center SPC 5362Ann ArborMI48109

Abstract

Background and Aims

Clip closure of the mucosal defect after resecting large (≥20 mm) nonpedunculated colorectal polyps reduces postprocedure bleeding and is cost saving for payers. Clip costs are not reimbursed by payers, posing a major barrier to adoption of this technique in the community. We aimed to determine appropriate clip costs to support broader use of this procedure in practice.

Methods

We performed budget impact analysis using our recent decision analytic model, comparing prophylactic clip closure with no clip closure on national cost and outcomes data, to determine the maximum feasible clip price while maintaining cost savings in practice. Sensitivity analyses were performed on important clinical factors.

Results

In the original model, the baseline postprocedure bleeding risk was 6.8%, increasing cost of care by $614.11 averaged among all patients undergoing large polyp resection without clip closure. Prophylactic clip closure of only large right-sided polyps reduced postprocedure bleeding risk by 70.7% but resulted in cost saving only if the price of clips was $100 or less. Comparatively, prophylactic clip closure of large left-sided polyps had no clinical benefit and was not cost saving. Clip closure strategies focused only on extra-large polyps (≥40 mm), or patients taking antithrombotics regardless of polyp characteristics, were only minimally cost saving. Cost savings and maximum tolerated clip prices depended on medical comorbidity, which directly influences the costs of care to manage postprocedure bleeding.

Conclusions

Prophylactic clip closure after endoscopic resection of large colon polyps, particularly those in the right colon segment, is cost saving but requires clip costs less than $100. Translating these findings into practice requires gastroenterology practices to obtain reimbursement from payers for improved clinical outcomes and to align commercial clip prices with this clinical indication.

Il testo completo di questo articolo è disponibile in PDF.

Abbreviations : CI, CMS


Mappa


 DISCLOSURE: Dr Law was a consultant for Olympus America and received royalties from UpToDate. Dr Rex was a consultant for Olympus Corporation, Boston Scientific, Medtronic, Aries, Braintree Laboratories; received research support from EndoAid, Olympus Corporation, Medivators, Erbe USA; and has ownership in Satisfai Health. Dr Pohl received research grants from Boston Scientific, US Endoscopy, and Aries Pharmaceuticals. Dr Feagins, sponsored clinical research trial with Corona, Inc. Dr Crockett, clinical trial agreements/research support from Freenome, Guardant Health, Exact Sciences, ColoWrap; consulting for IngenioRx; general payments/minor food and beverage from Ferring Pharmaceuticals, Salix Pharmaceuticals, and Boston Scientific. Dr Wallace consulted for Virgo Inc, Cosmo/Aries Pharmaceuticals, Anx Robotica, Covidien; obtained research grants from Fujifilm, Boston Scientific, Olympus, Medtronic, Ninepoint Medical, Cosmo/Aries Pharmaceuticals; held stock options in Virgo, Inc; consulted on behalf of Mayo Clinic for GI Supply (2018), Endokey, Endostart, Boston Scientific, MicroTek; received general payments/minor food and beverages from Synergy Pharmaceuticals, Boston Scientific, Cook Medical. All other authors disclosed no financial relationships relevant to this publication.
 See CME section; p. 1378.


© 2020  American Society for Gastrointestinal Endoscopy. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 91 - N° 6

P. 1353-1360 - giugno 2020 Ritorno al numero
Articolo precedente Articolo precedente
  • Cold snare piecemeal EMR of large sessile colonic polyps ?20 mm (with video)
  • Dileep Mangira, Karla Cameron, Koen Simons, Simon Zanati, Richard LaNauze, Spiro Raftopoulos, Gregor Brown, Alan Moss
| Articolo seguente Articolo seguente
  • Family history of colorectal cancer and prevalence of advanced colorectal neoplasia in asymptomatic screened populations in different age groups
  • Masau Sekiguchi, Yasuo Kakugawa, Keiko Nakamura, Minori Matsumoto, Yutaka Tomizawa, Yoshitaka Murakami, Yutaka Saito, Takahisa Matsuda

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.